Ignite Creation Date:
2025-12-24 @ 8:03 PM
Ignite Modification Date:
2026-02-07 @ 6:42 AM
Study NCT ID:
NCT02173704
Status:
COMPLETED
Last Update Posted:
2020-08-25
First Post:
2014-06-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Meningococcal B Recombinant Vaccine When Administered Concomitantly With Routine Vaccines to Healthy Infants of 2 Months of Age and Older, in Taiwan.
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-09-11
Start Date Type:
ACTUAL
Primary Completion Date:
2015-12-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-06-17
Completion Date Type:
ACTUAL
First Submit Date:
2014-06-05
First Submit QC Date:
None
Study First Post Date:
2014-06-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-02-20
Results First Submit QC Date:
None
Results First Post Date:
2018-06-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2016-02-03
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2020-08-13
Last Update Post Date:
2020-08-25
Last Update Post Date Type:
ACTUAL